ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Themes
      • Active ETF
      • Artificial Intelligence
      • Beyond Basic Beta
      • China Insights
      • Climate Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Education
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Managed Futures
      • Market Insights
      • Modern Alpha
      • Responsible Investing
      • Retirement Income
      • Tax Efficient Income
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Commodities
        • Gold/Silver/Critical Minerals
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook Channel
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Disruptive Technology Channel
  2. ARKG Holding Senti Biosciences Increases 22%
Disruptive Technology Channel
Share

ARKG Holding Senti Biosciences Increases 22%

Elle CarusoOct 13, 2022
2022-10-13

U.S. equities across all sectors are rebounding Thursday following the release of a hotter-than-expected inflation report. 

After recent volatility, shares of Senti Biosciences have increased nearly 22% on Thursday, bringing its one-month returns to nearly 72%. The stock traded up around 15%, 105%, and 23% last Monday, Tuesday, and Thursday, respectively, before dropping around 31% in a very weak market on Friday, ARK Invest wrote on October 8. 

The stock’s upward move began late last month after Chardan and Bank of America initiated coverage with “buy” ratings, according to ARK. 

“Recently, Senti also announced that it will present data on SENTI-401––an allogeneic logic-gated CAR-NK cell therapy for the treatment of CEA-Expressing solid tumors––at the Society of Immunotherapy and Cancer meeting in November,” ARK wrote in weekly commentary. “Senti Biosciences uses genetic logic circuit technology to develop highly precise medicines and cell therapy treatments for a broad range of indications. Its technology potentially could target malignancies by enabling cells to sense and adapt to the tumor microenvironment.”

Investors looking to add exposure to the companies involved in the genomics revelation should consider the ARK Genomic Revolution ETF (ARKG A-), which charges a 75 basis point expense ratio.

ARKG is an actively managed equity strategy that aims to provide exposure to DNA sequencing technology, gene editing, CRISPR, therapeutics, agricultural biology, and molecular diagnostics. 

Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their businesses, according to the firm.

ARKG typically holds between 40 and 60 securities and charges an expense ratio of 75 basis points. 

Top holdings in the fund as of October 13 include Ionis Pharmaceuticals (IONS, 7.37%), Exact Sciences Corp (EXAS, 6.66%), Caredx Inc (CDNA, 4.50%), Beam Therapeutics Inc (BEAM, 4.28%), Intellia Therapeutics Inc (NTLA, 4.35%), CRISPR Therapeutics AG (CRSP, 4.22%), Teladoc Health Inc (TDOC, 4.20%), Ginkgo Bioworks Holdings Inc (DNA, 4.14%), Fate Therapeutics Inc (FATE, 3.88%), and Schrodinger Inc (SDGR, 3.76%), according to the fund’s website.

For more news, information, and strategy, visit our Disruptive Technology Channel.

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X